Testing CPAP and PAP devices

CPAP, BiPAP, APAP, and related positive airway pressure devices move filtered, humidified, or conditioned air through blowers, masks, tubing, reservoirs, filters, and accessories. Aerosol, bioaerosol, chemical-emissions, cleaning, and breathing-simulation studies help answer questions outside routine electrical or mechanical verification. ISO 18562, ISO 16000, ISO 16890, FDA reprocessing guidance, and ISO 17025 records shape testing when:

  1. Particle emissions from blowers, foam, filters, or aged components need ISO 18562 or ISO 16000 aligned chamber evidence.
  2. VOC, aldehyde, ozone, or cleaner residues from breathing pathways require ISO 18562 and ISO 16000 gas-phase characterization.
  3. Humidifier reservoirs, masks, or tubing need bioaerosol carryover studies with ASTM E2720 context and ISO 17025 records.
  4. Inline filters, intake filters, or bacterial and viral filter accessories require ISO 16890 or EN 1822 aligned removal data.
  5. Cleaning, ozone exposure, UV exposure, or repeated reprocessing may affect materials under ASTM D543, ISO 2812, or FDA guidance.

Use this page when PAP device operation, reuse, cleaning, aging, or accessory changes may affect what reaches the patient breathing pathway. The study plan defines the device state, operating mode, flow profile, challenge material, analytical endpoint, controls, and reporting limits before testing starts.

Core testing menu for PAP device programs

PAP device programs often combine emissions, breathing-pathway chemistry, microbial carryover, filtration, cleaning, and modeling. Select the test menu by component, use condition, and documentation need.

Test method options

MethodStrengthsTradeoffAligned with
Operating particle emissions screen
  • Background-corrected chamber or fixture runs quantify particles from blowers, foam, filters, humidifiers, tubing, or aged PAP components.
  • ISO 18562 and ISO 16000 context supports breathing-pathway and indoor-air documentation without implying electrical safety certification.
Particle source attribution may require component isolation, aging controls, or material history from the sponsor.
ISO 17025ISO 18562ISO 16000
Breathing-pathway VOC and by-product profile
  • FTIR, TD-GC/MS, DNPH/HPLC, and ozone monitoring characterize chemical emissions from PAP flow paths, cleaners, materials, or aged parts.
  • ISO 18562 and ISO 16000 alignment connects target analytes, sampling locations, chamber conditions, and reporting limits.
Untargeted screens can miss decision-specific residues; target analytes should be selected during protocol development.
ISO 18562ISO 16000
Humidifier and bioaerosol carryover study
  • Surrogate or organism challenges evaluate microbial transport through reservoirs, tubing, masks, leak ports, and downstream breathing zones.
  • ASTM E2720 and ISO 17025 records frame challenge generation, recovery, controls, sampling locations, and biosafety assumptions.
Results are specific to the organism, surrogate, humidity, flow path, and cleaning state defined in the study.
ASTM E2720ISO 17025
Filter and accessory performance check
  • Upstream and downstream particle data characterize inline filters, intake filters, bacterial or viral filters, and accessory assemblies.
  • ISO 16890 and EN 1822 alignment supports particle removal, pressure-drop, and size-resolved performance interpretation.
Filter efficiency data does not certify the complete PAP device or establish clinical performance.
ISO 16890 / EN 1822ISO 17025
Cleaning, aging, and materials compatibility support
  • Repeated cleaning, ozone exposure, UV exposure, or aging studies compare residues, materials, VOCs, particles, and visible changes.
  • ASTM D543, ISO 2812, and USP <1072> connect cleaner exposure to reportable compatibility evidence.
Acceptance limits usually come from the sponsor's risk assessment, instructions for use, or product requirements.
ASTM D543 / ISO 2812 / USP <1072>
Breathing simulation and CFD-supported transport
  • Ventilator, mannequin, leak-port, and mask fixtures evaluate how flow, breathing profile, and interface geometry affect transport.
  • CFD can map flow paths, sampling locations, humidifier carryover, and particle or VOC transport under defined assumptions.
Simulation and CFD support interpretation; they do not replace clinical evaluation, software validation, or full device clearance.
ISO 17025

Setup configurations

Every PAP device study starts with the device model, component set, cleaning or aging history, use condition, and endpoint. The configuration defines the complete unit or isolated component, flow and breathing profile, humidification state, leak path, chamber or fixture geometry, sampling locations, controls, target analytes, and replicate plan. These dimensions are fixed before execution:

Device interfaces

Complete PAP units, blowers, masks, tubing, humidifier tanks, filters, foam-containing components, leak ports, and custom adapters tested as configured.

Flow & actuation profiles

Steady PAP flow, cyclic breathing, ramp settings, heated humidification, mask leak, cleaning cycle, and accessory state documented per run.

Sample numbers

Device count, component count, replicate runs, background checks, positive controls, negative controls, and comparator units sized to variability.

Environmental controls

Temperature, RH, chamber background, humidifier state, conditioning history, ozone or UV exposure, and sampling positions logged for each endpoint.

Analytical endpoints

Particle sizing, VOC speciation, aldehyde profile, ozone readings, microbial recovery, residue analytics, filtration efficiency, or CFD outputs selected at planning.

Quality frame for PAP device testing

PAP device studies separate accredited laboratory records from aligned breathing-pathway, indoor-air, and filtration standards. The same labels shown above define calibration, controls, and reporting language.

  • ISO 17025AccreditedLaboratory competence, method records, calibration traceability, and QA review.
  • ISO 18562AlignedBreathing-gas pathway context for particles, VOCs, and leachables.
  • ISO 16000AlignedIndoor-air sampling strategy for VOCs, aldehydes, gases, and particles.
  • ISO 16890 / EN 1822AlignedParticle filtration context for intake, inline, and accessory filters.

Key data outputs & reporting

PAP device reports connect the tested configuration to measured breathing-pathway evidence. Outputs can include particle concentration, size distribution, emission rate, VOC or aldehyde profiles, ozone trends, cleaner residues, microbial recovery, log reduction, filter efficiency, pressure drop, leak-sensitive transport, CFD assumptions, QA/QC records, and technical conclusions. Programs comparing cleaned, aged, refurbished, or design-change units receive extended deliverables.

Primary outputs

  • Particle concentration, size distribution, and emission rate by PAP mode, component, background condition, and sampling location.
  • VOC, aldehyde, ozone, cleaner-residue, or material off-gassing results tied to breathing-pathway configuration and exposure history.
  • Bioaerosol recovery, viable counts, gene copies, carryover results, or log reduction for humidifier, tubing, mask, or filter studies.
  • Filter efficiency, pressure drop, breathing-profile records, leak-path observations, and CFD outputs where included.

Deliverables

#FormatContents
01PDF reportProtocol, setup, controls, deviations, results, limitations, and conclusions.
02CSV / XLSX datasetsParticle, VOC, microbial, filtration, flow, and replicate tables.
03FiguresEmission trends, size spectra, response curves, sampling maps, and condition comparisons.
Extended deliverables · multi-arm comparability · stability · predicate studies
  • Condition comparison packSide-by-side outputs for new, aged, cleaned, refurbished, or exposed PAP components.
  • Risk-file appendixControls, assumptions, limitations, and scope boundaries organized for technical or regulatory review.

QA / QC & data integrity

PAP device studies use controls that separate true emissions, carryover, or filter behavior from background, tubing losses, chamber effects, sampler recovery, and analytical variability. Records are maintained under the ISO 17025 quality system from receipt through final review. Device configuration, calibration, operating state, environmental conditions, exclusions, and uncertainty contributors are documented.

Background, blank, negative, positive, recovery, device-off, and post-cleaning controls selected for the particle, bioaerosol, gas, VOC, or residue endpoint.

Flow meters, particle counters, samplers, gas analyzers, balances, environmental probes, and analytical instruments checked against calibration records.

Mask, tubing, humidifier, filter, leak-port, cleaner exposure, and aging state documented with sample identity and chain of custody.

Chamber background, carryover, sampling-line loss, recovery, RH, temperature, and operating mode logged before condition comparisons.

Raw data, calculations, deviations, invalid runs, replicate rules, exclusions, and uncertainty contributors reviewed before report release.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Quick answers to questions PAP device manufacturers, accessory developers, refurbishing teams, and quality groups ask when scoping a study. Topics include method selection, complete-system versus component testing, ISO 18562 alignment, humidifier carryover, cleaning or ozone exposure, sample needs, timeline drivers, deliverables, regulatory boundaries, accessory states, endpoint selection, and where ARE Labs' defined testing support ends.

Q.Can ARE Labs test a complete CPAP device?
A.Yes. Studies can use complete PAP systems or isolated components such as masks, tubing, filters, humidifier chambers, blower assemblies, and cleaned or aged accessories.
Q.Do you provide ISO 18562 aligned testing?
A.ARE Labs can design breathing-gas pathway studies aligned with ISO 18562 where the endpoint, component, flow path, and reporting objective fit the method scope.
Q.Can you evaluate ozone or UV cleaner exposure?
A.Yes. Studies can compare baseline and post-exposure particles, VOCs, residues, microbial recovery, material observations, and breathing-pathway outputs.
Q.Can you evaluate humidifier microbial carryover?
A.Yes. We can design microbial or surrogate challenge studies for humidifier reservoirs, tubing, masks, leak ports, and downstream breathing-zone locations.
Q.What determines sample count and timeline?
A.Device variability, endpoints, replicates, microbial recovery, aging cycles, cleaning cycles, fixture complexity, and analytical turnaround drive sample count and timeline.
Q.Does this certify the PAP device?
A.No. ARE Labs supports defined aerosol, bioaerosol, emissions, filtration, cleaning, and modeling evidence. Electrical safety, software validation, clinical evidence, labeling, full device clearance, and product certification may require additional specialists.